Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Note 9 - Other Expenses (Tables)

v3.10.0.1
Note 9 - Other Expenses (Tables)
 9 Months Ended
Sep. 30, 2018
Statement Line Items [Line Items]  
Disclosure of components of research and development expense [text block]
    Three months ended
September 30,		     Nine months ended
September 30,		  
    2018     2017     2018     2017  
Program costs, excluding salaries   $
2,773
     $
1,017
     $
7,249
     $
2,956
  
Salaries    
502
      
321
      
1,448
      
1,064
  
License fee, CrystalGenomics (a),(b)    
-
      
-
      
5,000
      
-
  
Stock-based compensation    
307
      
43
      
826
      
168
  
Depreciation and amortization    
9
      
9
      
26
      
25
  
    $
3,591
     $
1,390
     $
14,549
     $
4,213
  
Disclosure of components of general and administrative expense [text block]
    Three months ended
September 30,		     Nine months ended
September 30,		  
    2018     2017     2018     2017  
                         
General and administrative excluding salaries   $
853
     $
712
     $
3,149
     $
1,980
  
Salaries    
503
      
483
      
1,577
      
1,784
  
Stock-based payment financing fees (note 6(a)(iii)    
-
      
-
      
600
      
-
  
Stock-based compensation    
644
      
112
      
2,869
      
498
  
Depreciation and amortization    
20
      
12
      
38
      
40
  
    $
2,020
     $
1,319
     $
8,233
     $
4,302
  
Disclosure of finance income (cost) [text block]
    Three months ended
September 30,		     Nine months ended
September 30,		  
    2018     2017     2018     2017  
Foreign exchange loss   $
-
     $
-
     $
20
     $
-
  
Disclosure of finance income [text block]
    Three months ended
September 30,		     Nine months ended
September 30,		  
    2018     2017     2018     2017  
Interest income   $
80
     $
21
     $
198
     $
40
  
Foreign exchange gain    
9
      
48
      
-
      
102
  
    $
89
     $
69
     $
198
     $
142